Journal of Geriatric Oncology · 2021 · 41 citations · 24 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunotherapyCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsImmune Checkpoint RegulationImmune-related Adverse EventsImmunotherapy SafetyCheckpoint Inhibitor AntibodiesCheckpoint Inhibitor Toxicity ManagementImmune Checkpoint Inhibitor ResponseImmune Checkpoint Inhibitor TherapyImmune Checkpoint Inhibitor Toxicity GradingImmune Checkpoint ResistanceOverall MortalityResistance To Checkpoint Inhibitors
24
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text